SPARX3 Parkinson Disease Study
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
- Sex: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase III
- Conditions Being Studied: Brain and Nervous System, Parkinsons Disease
Study Purpose
The purpose of this study is to compare the effects of two different levels of exercise intensity and to learn more about effects of aerobic exercise on people with Parkinson’s disease (PD). This study will help us better understand what exercise guidelines should be used in the future.
Who Can Participate
Participants diagnosed with Parkinson’s disease and are naïve to drug treatment may be eligible for this study.
Locations
UH Cleveland Medical Center
11100 Euclid Ave
Cleveland OH, 44106
UH Suburban Health Center
1611 S Green Rd
South Euclid OH, 44121
UH Westlake Health Center
960 Clague Rd
Westlake OH, 44145
- UH IRB: SITE00001423
- StudyID: 2021-0534
- ClinicalTrials.gov: NCT04284436
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422